GRAMANTIERI, LAURA
GRAMANTIERI, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale esterno ed autonomi
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells
2025 Rambaldelli, G.; Asghar, S.; Venturi, G.; Zacchini, F.; Serra, M.; Giovannini, C.; Gramantieri, L.; Bernini, M.; Inga, A.; Dassi, E.; Montanaro, L.
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma
2025 Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alimenti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C.
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement
2025 Monti, Elisa; Galvani, Giuseppe; Leoni, Ilaria; Vianello, Clara; Bella, Marco; D’Amico, Federica; Roggiani, Sara; Elena Cifarelli, Maria; Marinelli, Sara; Giovannini, Catia; Gramantieri, Laura; Stefanelli, Claudio; Turroni, Silvia; Fornari, Francesca
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma
2025 Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, Luca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment
2025 Monti, Elisa; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Marinelli, Sara; Marisi, Giorgia; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini1, Catia; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients.
2024 Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marinelli, S.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Giovannini, C.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Negrini, M.; Piscaglia, F.; Stefanelli, C.; Gramantieri, L.; Fornari, F.
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients.
2024 Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; Stefanelli, C.; Gramantieri, L.; Fornari, F.
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC
2024 Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Gramantieri, Laura
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
2024 Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, Claudio Stefanelli, Laura Gramantieri, Francesca Fornari
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
2024 Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gramantieri, Laura; Giovannini, Catia
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma
2024 Monti, Elisa; Leoni, Ilaria; Galvani, Giuseppe; Vianello, Clara; Giovannini, Catia; Vasuri, Francesco; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
2023 Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariarosaria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma
2023 Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, Camelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
2022 Gramantieri, Laura; Fornari, Francesca
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma
2022 Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma
2022 Fornari Francesca; Gramantieri Laura
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
2021 Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells | Rambaldelli, G.; Asghar, S.; Venturi, G.; Zacchini, F.; Serra, M.; Giovannini, C.; Gramantieri, L....; Bernini, M.; Inga, A.; Dassi, E.; Montanaro, L. | 2025-01-01 | NON-CODING RNA RESEARCH | - | 1.01 Articolo in rivista | 1-s2.0-S2468054025000526-main.pdf; file supplementari.zip |
| Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma | Gramantieri, L.; Montagner, A.; Arleo, A.; Suzzi, F.; Bassi, C.; Tovoli, F.; Bruccoleri, M.; Alim...enti, E.; Fornari, F.; Iavarone, M.; Negrini, M.; Piscaglia, F.; Giovannini, C. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | Early CTLA4 increase in CD45+ blood cells_ an emerging biomarker of atezolizumab-bevacizumab resistance and worse survival in advanced hepatocarcinoma.pdf; mmc1.docx |
| Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement | Monti, Elisa; Galvani, Giuseppe; Leoni, Ilaria; Vianello, Clara; Bella, Marco; D’Amico, Federica;... Roggiani, Sara; Elena Cifarelli, Maria; Marinelli, Sara; Giovannini, Catia; Gramantieri, Laura; Stefanelli, Claudio; Turroni, Silvia; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma | Leoni, Ilaria; Galvani, Giuseppe; Monti, Elisa; Vianello, Clara; Valenti, Francesca; Pincigher, L...uca; Grolla, Ambra A; Moro, Marianna; Coada, Camelia A; Perrone, Alessandro; Righi, Valeria; Marinelli, Sara; Ravegnini, Gloria; Giovannini, Catia; Baldassarre, Maurizio; Pariali, Milena; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Domenicali, Marco; Negrini, Massimo; Piscaglia, Fabio; Fato, Romana; Stefanelli, Claudio; Gramantieri, Laura; Bergamini, Christian; Fornari, Francesca | 2025-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-26-03808-s001.zip; ijms-26-03808+(1)_compressed.pdf |
| miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment | Monti, Elisa; Vianello, Clara; Leoni, Ilaria; Galvani, Giuseppe; Marinelli, Sara; Marisi, Giorgia...; Casadei Giardini, Andrea; Giuseppe Foschi, Francesco; Giovannini1, Catia; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca | 2025-01-01 | - | - | 4.03 Poster | - |
| Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma | Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti... E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C. | 2024-01-01 | EUROPEAN JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | Eur J Immunol - 2023 - Gramantieri - Circulating CD8 lymphocytes predict respo.pdf; eji5648-sup-0001-suppmat.pdf |
| CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. | Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marinelli, S.; Marisi, G.; Casadei Gardini, A.; ...Foschi, G. F.; Giovannini, C.; Ravaioli, M.; Cescon, M.; Vasuri, F.; Negrini, M.; Piscaglia, F.; Stefanelli, C.; Gramantieri, L.; Fornari, F. | 2024-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.03 Poster | - |
| miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. | Vianello, C.; Leoni, I.; Galvani, G.; Monti, E.; Marisi, G.; Casadei Gardini, A.; Foschi, G. F.; ...Stefanelli, C.; Gramantieri, L.; Fornari, F. | 2024-01-01 | - | - | 4.03 Poster | - |
| Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC | Arleo, Andrea; Montagner, Annapaola; Giovannini, Catia; Suzzi, Fabrizia; Piscaglia, Fabio; Graman...tieri, Laura | 2024-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | P07 - Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC.pdf |
| Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response | Clara Vianello, Elisa Monti, Ilaria Leoni, Giuseppe Galvani, Catia Giovannini, Fabio Piscaglia, C...laudio Stefanelli, Laura Gramantieri, Francesca Fornari | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | Vianello cancers-16-00766_2024.pdf |
| Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies | Montagner, Annapaola; Arleo, Andrea; Suzzi, Fabrizia; D'Assoro, Antonino B.; Piscaglia, Fabio; Gr...amantieri, Laura; Giovannini, Catia | 2024-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | P08 - Notch signaling and PD1 PDL1 interaction in hepatocellular carcinoma potentialities of combined therapies.pdf |
| Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma | Monti, Elisa; Leoni, Ilaria; Galvani, Giuseppe; Vianello, Clara; Giovannini, Catia; Vasuri, Franc...esco; Piscaglia, Fabio; Stefanelli, Claudio; Gramantieri, Laura; Fornari, Francesca | 2024-01-01 | - | - | 4.03 Poster | - |
| Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma | Giovannini, Catia; Suzzi, Fabrizia; Tovoli, Francesco; Bruccoleri, Mariangela; Marseglia, Mariaro...saria; Alimenti, Eleonora; Fornari, Francesca; Iavarone, Massimo; Piscaglia, Fabio; Gramantieri, Laura | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | Cancers 2023.pdf |
| MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma | Bergamini, Christian; Leoni, Ilaria; Rizzardi, Nicola; Melli, Mattia; Galvani, Giuseppe; Coada, C...amelia Alexandra; Giovannini, Catia; Monti, Elisa; Liparulo, Irene; Valenti, Francesca; Ferracin, Manuela; Ravaioli, Matteo; Cescon, Matteo; Vasuri, Francesco; Piscaglia, Fabio; Negrini, Massimo; Stefanelli, Claudio; Fato, Romana; Gramantieri, Laura; Fornari, Francesca | 2023-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | miR-494 metabolism.pdf; 23498179.zip |
| Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area | Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D...'errico A.; Piscaglia F.; Giovannini C. | 2022-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 86. adducts.pdf; nutrients-14-01652-s001.zip |
| Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research | Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri | 2022-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | JHC-347946-animal-models-of-hepatocellular-carcinoma--current-applicati.pdf |
| MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing? | Gramantieri, Laura; Fornari, Francesca | 2022-01-01 | ONCOSCIENCE | - | 1.04 Replica / breve intervento (e simili) | oncoscience-v9-564.pdf |
| MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma | Laura Gramantieri, Francesca Fornari, Catia Giovannini, Davide Trere | 2022-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | biomolecules-12-00930.pdf |
| Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma | Fornari Francesca; Gramantieri Laura | 2022-01-01 | - | Elsevier | 2.01 Capitolo / saggio in libro | - |
| Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions | Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L | 2021-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | Elucidating the Molecular Basis of Sorafenib 2021.pdf |